Trial intelligence / Profile preview

Zishen Yutai Pill for IVF-ET outcomes in diminished ovarian reserve

ChiCTR2100048441Phase 4Recruiting

Sponsor
Reproductive Hospital affiliated with Shandong University
Start
Aug 2019
Countries
1
01

Overview

Phase 4, randomised trial of Zishen Yutai Pill in Diminished Ovarian Reserve (DOR) and female infertility (2 arms), sponsored by Reproductive Hospital affiliated with Shandong University. Primary endpoint: Clinical pregnancy outcome. Started Aug 2019; status: recruiting.

02

Drugs

Zishen Yutai Pill
03

Conditions

Diminished Ovarian Reserve (DOR)female infertility

Beyond the preview

Go deeper on ChiCTR2100048441.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100048441.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call